Capsule maker ups track and trace with molecular tagging

By Flora Southey

- Last updated on GMT

ACG says adding Applied DNA Sciences’ molecular tagging and authentication technology to its capsule products will increase supply chain security.

According to the memorandum of understanding (MoU), the tablet and capsule manufacturer will use Applied DNA Sciences’ SigNature technology to develop molecularly tagged empty hard-shell capsules.

Under the agreement, a molecular tag embedded in ACG’s gelatine and hydroxypropylmethyl cellulose (HPMC) capsules will allow for authentication across the pharma supply chain.

“The ability to forensically test a capsule in the field and quickly prove its provenance is a powerful tool for all nodes of the pharmaceutical supply chain and will ensure a more secure and traceable global pharmaceutical supply chain,” ​said Applied DNA Sciences’ president James Hayward.

ACG CEO Selwyn Noronha explained that testing and authentication will be undertaken by pharmaceutical manufacturer, using either one of two options: “One is using a field device/kit in a warehouse. The second is by availing services of a third-party testing hub run by Advance DNA Sciences.”

“The end consumer will not be able to do the testing,” ​he added.

Track & trace

Although serialization is specific to pharmaceutical packaging, Noronha told us adding an authentication feature to a hard capsule shell conforms to track and trace efforts globally.

“With the introduction of stricter regulatory norms and measures across the globe, the pressure lies increasingly in improving existing supply chain safeguards,” ​said Noronha.

“This association will equip pharmaceutical companies with greater capabilities to thwart the threat of counterfeits by providing an amplified traceability solution across the supply chain,” ​he added.

Enhanced confidence

Noronha told us its drugmaker clients will benefit from the MoU, as it will help improve patients’ trust.

“ACG’s capsules with this solution will thus benefit manufacturers to enhance the patient’s trust and confidence in their products,” ​he said.

Last year​, Applied DNA Sciences announced a MoU with Colorcon Inc., under which the excipient and coating firm applied the “molecular taggant” technology to its film coating, ink and colour dispersion systems. 

Related news

Show more

Related products

show more

Pulmonary Delivery of Orally Inhaled Therapeutics

Pulmonary Delivery of Orally Inhaled Therapeutics

Content provided by Catalent Pharma Solutions | 19-Oct-2023 | Product Brochure

New classes and indications of orally inhaled therapeutics are rapidly expanding, with the development pipeline increasingly featuring both large and small...

Related suppliers

Follow us


View more